Resources

Type of publications
Regions
Diseases

5192 results found

2011 ∙ Plotkin, S. Leuridan, E. Van Damme, P.

Hepatitis B and the Need for a Booster Dose

  • All age groups
  • Hepatitis B
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Not applicable
2011 ∙ Fabrizi, F. Dixit, V. Martin, P. Messa, P.

Hepatitis C virus and the immunological response to hepatitis B virus vaccine in dialysis patients: Meta-analysis of clinical studies

  • Adults
  • Older adults
  • Hepatitis B
  • Hepatitis C
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2011 ∙ Farez, M. F. Correale, J.

Immunizations and risk of multiple sclerosis: Systematic review and meta-analysis

  • Children
  • Adults
  • Travellers
  • Tuberculosis
  • Influenza
  • Hepatitis B
  • Poliomyelitis
  • Typhoid
  • Diphtheria
  • Tetanus
  • Measles
  • Mumps
  • Rubella
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2011 ∙ Beyer, W. E. P. Nauta, J. J. P. Palache, A. M. Giezeman, K. M. Osterhaus, A. D. M. E.

Immunogenicity and safety of inactivated influenza vaccines in primed populations: A systematic literature review and meta-analysis

  • All age groups
  • Influenza
  • Administration
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2011 ∙ Yin, J. K. Khandaker, G. Rashid, H. Heron, L. Ridda, I. Booy, R.

Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: Systematic review and meta-analysis

  • All age groups
  • Influenza
  • Administration
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2011 ∙ Rückinger, S. Dagan, R. Albers, L. Schönberger, K. von Kries, R.

Immunogenicity of pneumococcal conjugate vaccines in infants after two or three primary vaccinations: A systematic review and meta-analysis

  • Newborn
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2011 ∙ Ferroni, E. Jefferson, T.

Influenza

  • Adolescents
  • Adults
  • Older adults
  • Influenza
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2011 ∙ Beck, Charles R. McKenzie, Bruce C. Hashim, Ahmed B. Harris, Rebecca C. Zanuzdana, Arina Agboado, Gabriel Orton, Elizabeth Bechard-Evans, Laura Morgan, Gemma Stevenson, Charlotte Weston, Rachel Mukaigawara, Mitsuru Enstone, Joanne Augustine, Glenda Butt, Mobasher Kim, Sophie Puleston, Richard Dabke, Girija Howard, Robert O'Boyle, Julie O'Brien, Mary Ahyow, Lauren Denness, Helene Farmer, Siobhan Figureroa, Jose Fisher, Paul Greaves, Felix Haroon, Munib Haroon, Sophie Hird, Caroline Isba, Rachel Ishola, David A. Kerac, Marko Parish, Vivienne Roberts, Jonathan Rosser, Julia Theaker, Sarah Wallace, Dean Wigglesworth, Neil Lingard, Liz Vinogradova, Yana Horiuchi, Hiroshi Penalver, Javier Nguyen-Van-Tam, Jonathan S.

Influenza Vaccination for Immunocompromised Patients: Systematic Review and Meta-Analysis from a Public Health Policy Perspective

  • All age groups
  • Influenza
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2011 ∙ Scott, P. Moss, W. J. Gilani, Z. Low, N.

Measles vaccination in HIV-infected children: Systematic review and meta-analysis of safety and immunogenicity

  • Newborn
  • Children
  • Adolescents
  • Measles
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2011 ∙ Sinclair, David Abba, Katharine Zaman, K. Qadri, Firdausi Graves, Patricia M.

Oral vaccines for preventing cholera

  • All age groups
  • Cholera
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
High
Loading...